218 related articles for article (PubMed ID: 31267879)
1. Three Pt-Pt Complexes with Donor-acceptor Feature: Anticancer Activity, DNA Binding Studies and Molecular Docking Simulation.
Ashoo P; Yousefi R; Nabavizadeh SM; Aseman MD; Paziresh S; Ghasemi A; Saboury AA
Anticancer Agents Med Chem; 2019; 19(14):1762-1774. PubMed ID: 31267879
[TBL] [Abstract][Full Text] [Related]
2. Anticancer Activity Assessment and DNA Binding Properties of Two Binuclear Platinum (II) Complexes using Spectroscopic and Molecular Simulation Approaches.
Alavianmehr MM; Ashrafi A; Yousefi R; Haghighi MG; Abolmaali SS; Moosavi-Movahedi AA; Rad MNS
Anticancer Agents Med Chem; 2020; 20(17):2066-2073. PubMed ID: 32628598
[TBL] [Abstract][Full Text] [Related]
3. Cycloplatinated(II) Derivatives of Mercaptopurine Capable of Binding Interactions with HSA/DNA.
Aseman MD; Aryamanesh S; Shojaeifard Z; Hemmateenejad B; Nabavizadeh SM
Inorg Chem; 2019 Dec; 58(23):16154-16170. PubMed ID: 31721562
[TBL] [Abstract][Full Text] [Related]
4. New minor groove covering DNA binding mode of dinuclear Pt(II) complexes with various pyridine-linked bridging ligands and dual anticancer-antiangiogenic activities.
Franich AA; Živković MD; Ilić-Tomić T; Đorđević IS; Nikodinović-Runić J; Pavić A; Janjić GV; Rajković S
J Biol Inorg Chem; 2020 May; 25(3):395-409. PubMed ID: 32162071
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, cytotoxic activity and DNA interaction studies of new dinuclear platinum(ii) complexes with an aromatic 1,5-naphthyridine bridging ligand: DNA binding mode of polynuclear platinum(ii) complexes in relation to the complex structure.
Konovalov B; Živković MD; Milovanović JZ; Djordjević DB; Arsenijević AN; Vasić IR; Janjić GV; Franich A; Manojlović D; Skrivanj S; Milovanović MZ; Djuran MI; Rajković S
Dalton Trans; 2018 Oct; 47(42):15091-15102. PubMed ID: 30303498
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of series of diazine-bridged dinuclear platinum(II) complexes through in vitro toxicity and molecular modeling: correlation between structure and activity of Pt(II) complexes.
Senerovic L; Zivkovic MD; Veselinovic A; Pavic A; Djuran MI; Rajkovic S; Nikodinovic-Runic J
J Med Chem; 2015 Feb; 58(3):1442-51. PubMed ID: 25551180
[TBL] [Abstract][Full Text] [Related]
7. Homo- and heteroleptic Pt(II) complexes of ONN donor hydrazone and 4-picoline: A synthetic, structural and detailed mechanistic anticancer investigation.
Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Yang B; Koppireddi S; Lin Y; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2018 Jan; 143():1039-1052. PubMed ID: 29232581
[TBL] [Abstract][Full Text] [Related]
8. Investigating the anticancer properties of the two new platinum complexes with iso- and tert-pentylglycine by the DFT, molecular docking, and ADMET assessment and experimental confirmations.
Ramezani N; Eslami Moghadam M; Behzad M
J Biol Inorg Chem; 2021 May; 26(2-3):283-298. PubMed ID: 33616752
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, spectroscopic and biological studies of a fluorescent Pt(II) (terpy) based 1,8-naphthalimide conjugate as a DNA targeting agent.
Banerjee S; Kitchen JA; Bright SA; O'Brien JE; Williams DC; Kelly JM; Gunnlaugsson T
Chem Commun (Camb); 2013 Oct; 49(76):8522-4. PubMed ID: 23942760
[TBL] [Abstract][Full Text] [Related]
10. Half-Lantern Cyclometalated Platinum(II) Complexes as Anticancer Agents: Molecular Docking, Apoptosis, Cell Cycle Analysis, and Cytotoxic Activity Evaluations.
Hajipour F; Mahdavinia M; Fereidoonnezhad M
Anticancer Agents Med Chem; 2022; 22(6):1149-1158. PubMed ID: 34259151
[TBL] [Abstract][Full Text] [Related]
11. Anticancer activity and DNA-binding properties of novel cationic Pt(II) complexes.
Jamshidi M; Yousefi R; Nabavizadeh SM; Rashidi M; Haghighi MG; Niazi A; Moosavi-Movahedi AA
Int J Biol Macromol; 2014 May; 66():86-96. PubMed ID: 24530367
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, structures and anticancer potentials of platinum(II) saccharinate complexes of tertiary phosphines with phenyl and cyclohexyl groups targeting mitochondria and DNA.
Yilmaz VT; Icsel C; Turgut OR; Aygun M; Erkisa M; Turkdemir MH; Ulukaya E
Eur J Med Chem; 2018 Jul; 155():609-622. PubMed ID: 29920455
[TBL] [Abstract][Full Text] [Related]
13. Anticancer and DNA binding activities of platinum (IV) complexes; importance of leaving group departure rate.
Pouryasin Z; Yousefi R; Nabavizadeh SM; Rashidi M; Hamidizadeh P; Alavianmehr MM; Moosavi-Movahedi AA
Appl Biochem Biotechnol; 2014 Mar; 172(5):2604-17. PubMed ID: 24414990
[TBL] [Abstract][Full Text] [Related]
14. Dinuclear Platinum(II) Complexes with Bone-Targeting Groups as Potential Anti-Osteosarcoma Agents.
Zhang Z; Wang X; Luo C; Zhu C; Wang K; Zhang C; Guo Z
Chem Asian J; 2017 Jul; 12(13):1659-1667. PubMed ID: 28556606
[TBL] [Abstract][Full Text] [Related]
15. Anticancer activity assessment of two novel binuclear platinum (II) complexes.
Shahsavani MB; Ahmadi S; Aseman MD; Nabavizadeh SM; Rashidi M; Asadi Z; Erfani N; Ghasemi A; Saboury AA; Niazi A; Bahaoddini A; Yousefi R
J Photochem Photobiol B; 2016 Aug; 161():345-54. PubMed ID: 27289447
[TBL] [Abstract][Full Text] [Related]
16. Novel diindoloazepinone derivatives as DNA minor groove binding agents with selective topoisomerase I inhibition: Design, synthesis, biological evaluation and docking studies.
Kadagathur M; Devi GP; Grewal P; Sigalapalli DK; Makhal PN; Banerjee UC; Bathini NB; Tangellamudi ND
Bioorg Chem; 2020 Jun; 99():103629. PubMed ID: 32272367
[TBL] [Abstract][Full Text] [Related]
17. New bio-sensitive and biologically active single crystal of pyrimidine scaffold ligand and its gold and platinum complexes: DFT, antimicrobial, antioxidant, DNA interaction, molecular docking with DNA/BSA and anticancer studies.
Sankarganesh M; Dhaveethu Raja J; Sakthikumar K; Solomon RV; Rajesh J; Athimoolam S; Vijayakumar V
Bioorg Chem; 2018 Dec; 81():144-156. PubMed ID: 30121002
[TBL] [Abstract][Full Text] [Related]
18. Morpholine or methylpiperazine and salicylaldimine based heteroleptic square planner platinum (II) complexes: In vitro anticancer study and growth retardation effect on E. coli.
Rahman FU; Ali A; Khan IU; Duong HQ; Yu SB; Lin YJ; Wang H; Li ZT; Zhang DW
Eur J Med Chem; 2017 May; 131():263-274. PubMed ID: 28334655
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure elucidation of novel salophen-based dioxo-uranium(VI) complexes: In-vitro and in-silico studies of their DNA/BSA-binding properties and anticancer activity.
Ebrahimipour SY; Mohamadi M; Torkzadeh Mahani M; Simpson J; Mague JT; Sheikhshoaei I
Eur J Med Chem; 2017 Nov; 140():172-186. PubMed ID: 28923384
[TBL] [Abstract][Full Text] [Related]
20. The comparative study of the DNA binding and biological activities of the quaternized dicnq as a dicationic form and its platinum(II) heteroleptic cationic complex.
Yıldız U; Şengül A; Kandemir I; Cömert F; Akkoç S; Coban B
Bioorg Chem; 2019 Jun; 87():70-77. PubMed ID: 30878811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
